Christopher Richard Anzalone
Chief Executive Officer, Director · ARROWHEAD PHARMACEUTICALS, INC.
- 2024
- Dec 16, 2025
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Christopher Richard Anzalone files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- James C. Hamilton - $1.39M in ARWR purchases and sales in the last 12 months
- Michael S. Perry - $1.01M in ARWR purchases and sales in the last 12 months
- Daniel Joseph Apel - $934K in ARWR purchases and sales in the last 12 months
- Mauro Ferrari - $493K in ARWR purchases and sales in the last 12 months
- Hongbo Lu - $228K in ARWR purchases and sales in the last 12 months
- Adeoye Y. Olukotun - $174K in ARWR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Christopher Richard Anzalone?
Christopher Richard Anzalone is a corporate insider, tracked as Chief Executive Officer, Director of ARROWHEAD PHARMACEUTICALS, INC. (ARWR). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Christopher Richard Anzalone last file a Form 4?
The most recent primary Form 4 on record is dated 16 December 2025, one of 3 filings going back to 2024.
Has Christopher Richard Anzalone been buying or selling stock?
Recorded transactions: 0 open-market purchases and 16 open-market sales ($13.16M) across all tracked filings.
